These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37817517)

  • 1. Impact of Mesenchymal Stem Cells on the Gut Microbiota and Microbiota Associated Functions in Inflammatory Bowel Disease: A Systematic Review of Preclinical Evidence on Animal Models.
    Liu A; Li C; Wang C; Liang X; Zhang X
    Curr Stem Cell Res Ther; 2024; 19(7):981-992. PubMed ID: 37817517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis.
    Liu A; Liang X; Wang W; Wang C; Song J; Guo J; Sun D; Wang D; Song M; Qian J; Zhang X
    Stem Cell Res Ther; 2023 Sep; 14(1):271. PubMed ID: 37749611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota.
    Yang F; Ni B; Liu Q; He F; Li L; Zhong X; Zheng X; Lu J; Chen X; Lin H; Xu R; He Y; Zhang Q; Zou X; Chen W
    Stem Cell Res Ther; 2022 Sep; 13(1):475. PubMed ID: 36104756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy.
    Saadh MJ; Mikhailova MV; Rasoolzadegan S; Falaki M; Akhavanfar R; Gonzáles JLA; Rigi A; Kiasari BA
    Eur J Med Res; 2023 Jan; 28(1):47. PubMed ID: 36707899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6.
    Yang S; Liang X; Song J; Li C; Liu A; Luo Y; Ma H; Tan Y; Zhang X
    Stem Cell Res Ther; 2021 May; 12(1):315. PubMed ID: 34051868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose-Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model.
    Soontararak S; Chow L; Johnson V; Coy J; Wheat W; Regan D; Dow S
    Stem Cells Transl Med; 2018 Jun; 7(6):456-467. PubMed ID: 29635868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord mesenchymal stem cells regulate immunoglobulin a secretion and remodel the diversification of intestinal microbiota to improve colitis.
    Liu A; Wang X; Liang X; Wang W; Li C; Qian J; Zhang X
    Front Cell Infect Microbiol; 2022; 12():960208. PubMed ID: 36118029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Prospects of Mesenchymal Stem Cell and Their Derived Exosomes in the Regulation of the Gut Microbiota in Inflammatory Bowel Disease.
    Qiao Y; Tang X; Liu Z; Ocansey DKW; Zhou M; Shang A; Mao F
    Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell-gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect.
    Ocansey DKW; Wang L; Wang J; Yan Y; Qian H; Zhang X; Xu W; Mao F
    Clin Transl Med; 2019 Dec; 8(1):31. PubMed ID: 31872304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the interactions between the gut microbiota and the inflammatory response to ulcerative colitis in a mouse model of dextran sodium sulfate and possible mechanisms of action for treatment with PE&AFWE.
    Fu Q; Ma X; Li S; Shi M; Song T; Cui J
    Animal Model Exp Med; 2024 Apr; 7(2):83-97. PubMed ID: 38664929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease by inhibiting ERK phosphorylation in neutrophils.
    Wang G; Joel MDM; Yuan J; Wang J; Cai X; Ocansey DKW; Yan Y; Qian H; Zhang X; Xu W; Mao F
    Inflammopharmacology; 2020 Apr; 28(2):603-616. PubMed ID: 31938969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.
    Yang M; Gu Y; Li L; Liu T; Song X; Sun Y; Cao X; Wang B; Jiang K; Cao H
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive effect of mesenchymal stem cells on lung and gut CD8
    Xu Y; Zhu J; Feng B; Lin F; Zhou J; Liu J; Shi X; Lu X; Pan Q; Yu J; Zhang Y; Li L; Cao H
    Cell Prolif; 2021 May; 54(5):e13028. PubMed ID: 33738881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of intestinal mesenchymal stromal cells reduces colitis-associated cancer in C57BL/6J mice modulating the immune response and gut dysbiosis.
    Hidalgo-García L; Ruiz-Malagon AJ; Huertas F; Rodríguez-Sojo MJ; Molina-Tijeras JA; Diez-Echave P; Becerra P; Mirón B; Morón R; Rodríguez-Nogales A; Gálvez J; Rodríguez-Cabezas ME; Anderson P
    Pharmacol Res; 2023 Sep; 195():106891. PubMed ID: 37586618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells.
    Huldani H; Margiana R; Ahmad F; Opulencia MJC; Ansari MJ; Bokov DO; Abdullaeva NN; Siahmansouri H
    Int Immunopharmacol; 2022 Jun; 107():108698. PubMed ID: 35306284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner.
    Liu YJ; Tang B; Wang FC; Tang L; Lei YY; Luo Y; Huang SJ; Yang M; Wu LY; Wang W; Liu S; Yang SM; Zhao XY
    Theranostics; 2020; 10(12):5225-5241. PubMed ID: 32373209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.